India

LIC’s ₹17.5 Lakh Crore Portfolio: IT Stocks In, Banks Out as Insurer Defies Market Trends

LIC
New Delhi,18 Feb 2026, By PressRoom

In a bold strategic shift, the Life Insurance Corporation of India (LIC) has recalibrated its massive ₹17.5 lakh crore equity portfolio, making a contrarian bet on the information technology (IT) sector while reducing its exposure to banking heavyweights. As of February 18, 2026, the state-owned insurer has emerged as a major support pillar for the IT industry, plowing thousands of crores into stocks that other investors are exiting amid global AI disruption fears.

LIC’s IT sector holdings have surged from ₹1.82 lakh crore to ₹2.17 lakh crore, with the sector’s share in its total portfolio jumping to 12.43%. This aggressive buying spree comes at a time when many tech valuations have corrected by up to 30%, signaling LIC’s confidence that the current “AI anxiety” is a temporary market overreaction rather than a permanent threat to India’s outsourcing model.

The insurer has selectively picked companies with robust fundamentals and attractive valuations. The most significant additions include:

  • Tata Consultancy Services (TCS): LIC invested an estimated ₹3,136 crore in the tech leader.
  • HCL Technologies: A fresh infusion of ₹2,293 crore was directed here.
  • Coforge: In one of its most dramatic moves, LIC increased its stake from under 1% to 4.66%, betting on a recovery in the midcap IT space.

While LIC remains the largest domestic institutional investor in financial services, it has begun thinning its holdings in top-tier lenders. Financial services’ share of the portfolio contracted to 26.52% as the insurer offloaded shares in several banking giants:

  • State Bank of India (SBI): Single largest sale worth ₹3,080 crore.
  • HDFC Bank: Stakes worth ₹1,528 crore were liquidated.
  • Bank of Baroda: Reduced exposure by ₹1,173 crore.

Beyond banking, LIC also showed caution toward industrial and energy leaders, trimming positions in Larsen & Toubro (L&T) (₹2,442 crore) and Reliance Industries (₹2,367 crore).

This reshuffle highlights LIC’s role as a “financial shock absorber.” By buying when the market is fearful and selling into strength, the insurer manages long-term intergenerational equity for its millions of policyholders. The increase in Sun Pharma (₹2,942 crore) and NMDC further suggests a shift toward defensive health stocks and value-driven public sector undertakings.

As the government considers allowing up to 20% Foreign Direct Investment (FDI) in LIC via the automatic route through the recent Press Note 1 of 2026, the insurer’s refined portfolio positioning makes it an even more critical gauge for international investors looking at India’s long-term growth story.

Key Highlights:

  • Contrarian Strategy: LIC has increased its IT sector holdings to ₹2.17 lakh crore, buying heavily into TCS and HCL Tech despite broader market fears regarding AI disruption.
  • Banking Exit: The insurer offloaded over ₹3,000 crore in SBI and trimmed stakes in HDFC Bank and Bank of Baroda to rebalance its sectoral risk.
  • Portfolio Growth: LIC’s total equity portfolio now stands at approximately ₹17.5 lakh crore, reflecting a diversified approach across 283 listed stocks.
  • New Favorites: Midcap IT firm Coforge and healthcare giant Sun Pharma emerged as top picks, signaling a move toward value-driven and defensive investments.
PRPressRoom DeskNewsroomThe PressRoom newsroom covers the business of media, entertainment, technology and startups across India and the Gulf.
Free newsletter

The PressRoom Briefing

The day's most important media, entertainment, tech and business stories, in your inbox every morning.